-
Ardent Health Partners Inc (ARDT) PT Lowered at RBC Capital Amid Near-Term Headwind
-
Ardent Health Partners Inc (ARDT) PT Lowered to $17 at Loop Capital
-
Morgan Stanley Downgrades Ardent Health Partners Inc (ARDT) to Equalweight
-
KeyBanc on Ardent Health Partners Inc (ARDT): 'Big Miss and Guidance Cut'
-
Ardent Health Partners, Inc. (ARDT) Reports Q3 Loss of $0.17, provides guidance
-
Goldman Sachs Starts Ardent Health Partners Inc (ARDT) at Neutral
-
UBS Reiterates Buy Rating on Ardent Health Partners Inc (ARDT)
-
Ardent Health amends $777.5 million term loan, cuts rate by 50 basis points
-
Truist: 'We Remain Bullish on Ardent Health Partners Inc (ARDT)'
-
BofA Lists EHC and THC as Top Picks in Healthcare, Sees UHS and ARDT as Worst Positioned
-
UBS Starts Ardent Health Partners Inc (ARDT) at Buy
-
Ardent Health (ARDT) Files $500M Mixed Shelf
-
Ardent Health Partners Inc (ARDT) PT Lowered to $15 at JPMorgan
-
Ardent Health Partners, Inc. (ARDT) Reports Q2 EPS of $0.52; offers guidance
-
BofA Securities Downgrades Ardent Health Partners Inc (ARDT) to Underperform
-
KeyBanc 'Optimistic' on Ardent Health Partners Inc (ARDT) Stock Following Investor Meetings
-
Ardent Health Partners Inc (ARDT) changes name to Ardent Health Inc
-
Ardent Health (ARDT) names Chris Schoeplein as Chief Dev Officer
-
Ardent Health Partners Inc (ARDT) PT Lowered to $19 at Loop Capital
-
Guggenheim Starts Ardent Health Partners Inc (ARDT) at Buy
-
Ardent Health (ARDT) appoints Robert DeMichiei to Board
-
Ardent Health (ARDT) Appoints Dave Caspers as COO, Announces Other Leadership Promotions
-
Ardent Health Partners Inc (ARDT) PT Lowered to $19 at Mizuho
-
Ardent Health Partners Inc (ARDT) PT Lowered to $21 at RBC Capital Despite 'Solid 4Q'
-
Ardent Health Partners, Inc. (ARDT) Reports Q4 EPS of $0.81 ; Offers Guidance
-
These stocks will come under pressure as Republicans ready to deliver Medicaid cuts
-
KeyBanc Provides Healthcare Services Update: 'Positive Update from EVH Potentially the Most Impactful'
-
Loop Capital Reiterates Buy Rating on Ardent Health Partners Inc (ARDT)
-
BofA Securities Downgrades Ardent Health Partners Inc (ARDT) to Neutral
-
KeyBanc Starts Ardent Health Partners Inc (ARDT) at Overweight
-
Ardent Health (ARDT) Added to Russell 2000 and 3000 Indexes
-
Stephens Reiterates Overweight Rating on Ardent Health Partners Inc (ARDT)
-
Ardent Health (ARDT) Completes Term Loan Repricing
-
Ardent Health Partners Inc (ARDT) PT Raised to $21 at Loop Capital
-
Ardent Health Partners Inc (ARDT) PT Raised to $21 at Mizuho
-
Ardent Health Partners Inc (ARDT) PT Raised to $22 at Truist Securities
-
Loop Capital Starts Ardent Health Partners Inc (ARDT) at Buy
-
Truist Securities Starts Ardent Health Partners Inc (ARDT) at Buy
-
Mizuho Starts Ardent Health Partners Inc (ARDT) at Outperform
-
Morgan Stanley Starts Ardent Health Partners Inc (ARDT) at Overweight
-
JPMorgan Starts Ardent Health Partners Inc (ARDT) at Neutral
-
RBC Capital Starts Ardent Health Partners Inc (ARDT) at Outperform

